GPP
Great Point Partners Portfolio holdings
AUM
$154M
1-Year Return
2.36%
This Quarter Return
-1.38%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$506M
AUM Growth
+$22.3M
(+4.6%)
Cap. Flow
+$30.4M
Cap. Flow
% of AUM
6%
Top 10 Holdings %
Top 10 Hldgs %
51.22%
Holding
56
New
14
Increased
12
Reduced
14
Closed
12
Top Buys
| 1 |
Cytokinetics
CYTK
|
$17.6M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$17.4M |
| 3 |
AnaptysBio
ANAB
|
$17.2M |
| 4 |
Evolus
EOLS
|
$16.9M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$13.4M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$20.6M |
| 2 |
Ventyx Biosciences
VTYX
|
$13.1M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$12.5M |
| 4 |
PTC Therapeutics
PTCT
|
$11.5M |
| 5 |
Sarepta Therapeutics
SRPT
|
$9.46M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Ventyx Biosciences
VTYX
$185M
| – | – |
-400,695
| Closed | -$13.1M |
|
|
MRTX
52
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-133,000
| Closed | -$6.03M |
|
|
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-160,500
| Closed | -$20.6M |
|
|
ICPT
54
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-528,850
| Closed | -$6.54M |
|
|
ALBO
55
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| – | – |
-267,283
| Closed | -$5.78M |
|
|
CINC
56
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| – | – |
-1,019,153
| Closed | -$12.5M |
|